Tong-Chuan He

The University of Chicago Medical Center, USA

Tong‐Chuan He, a holder of the M.D. and Ph.D. degrees, is a well‐established investigator with more than 20 years of experience in basic biomedical and translational research, including cell signaling, cancer biology, stem cell biology, gene and cell‐based therapies, and regenerative medicine. He is currently a Tenured Faculty Member and the Director of Molecular Oncology Laboratory at the University of Chicago Medical Center. Dr. He received his medical school training from Chongqing Medical University in China and his Ph.D. degree in molecular and cell biology from the Pennsylvania State University, followed by a postdoctoral training at Howard Hughes Medical Institute and Johns Hopkins Medical Institution. He was the principal developer of the highly cited, widely used AdEasy technology, which has streamlined the effective generation of recombinant adenoviruses. He has coauthored more than 190 peer‐reviewed original articles, invited reviews, and book chapters, which have been cumulatively cited over 19,500 times with a current H‐index of 54 according to Google Scholar as of July 2014. In addition to his research activities, Dr. He has actively participated in the peer‐reviewing process for more than 30 journals, including many top tier journals. He is currently serving on the editorial boards for over 10 journals, including Journal of Biological Chemistry, Current Cancer Drug Targets, Laboratory Investigation, and American Journal of Stem Cells.

Biography Updated on 8 September 2014

Scholarly Contributions [Data Provided by ]